Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism p53 Y220C activators(Cellular Tumor Antigen p53 Y220C activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | CN | 16 Jun 2024 |